Interim results of a prospective, randomized, open-label, Phase 3 study of the long-term safety and efficacy of lasmiditan for acute treatment of migraine (the GLADIATOR study)

OBJECTIVES: To address the need for long-term lasmiditan data, the GLADIATOR study evaluated the safety (primary) and efficacy (secondary) of lasmiditan for the intermittent, acute treatment of migraine attacks for up to 1 year. METHODS: In this prospective, randomized, open-label, Phase 3 study, pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Brandes, Jan Lewis, Klise, Suzanne, Krege, John H, Case, Michael, Khanna, Rashna, Vasudeva, Raghavendra, Raskin, Joel, Pearlman, Eric M, Kudrow, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6779019/
https://www.ncbi.nlm.nih.gov/pubmed/31433669
http://dx.doi.org/10.1177/0333102419864132

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6779019/
https://www.ncbi.nlm.nih.gov/pubmed/31433669
http://dx.doi.org/10.1177/0333102419864132

Ejemplares similares